None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subject from 18-50 years of age. 2. Subject having Nasal congestion. 3. Subjects that are able to give written informed consent in a manner approved by the institutional ethics committee and comply with the requirements of the study. 4. Subject willing to avoid participation in any other interventional clinical trial for the duration of the study.
Exclusion criteria
Exclusion criteria: 1. Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including oral or parenteral corticosteroids. 2. Subject with Pollen allergy or nasal allergy. 3. Subjects that have participated in any other interventional clinical trial in the previous 90 days. 4. Subjects with known sensitivity to any of the constituents of the investigational product. 5. Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or procedures. 6. Chronic illness which may influence the outcome of the study. 7. Pregnant/nursing mothers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. VAS for Nasal congestion 2. SGA Timepoint: At T0min, T24hrs | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. PNIF ScoreTimepoint: At T0min, T30min | — |
Countries
India
Contacts
CCFT Laboratories